Cambodia’s health ministry today reported a seventh human H5N1 avian flu case for the month of June, a 36-year-old woman from ...

NIAID researchers and colleagues sought to confirm the presence of piperaquine-resistant infections in Cambodia by comparing the efficacy of dihydroartemisinin-piperaquine treatment in 204 malaria ...

New findings from NIAID confirm dihydroartemisinin-piperaquine, the first-line treatment for Plasmodium falciparum malaria infection in Cambodia, has failed in certain provinces due to parasite ...

The shift reflects the current public health situation, marked by declines in human cases as well as animal detections ...

A clinical trial in Cambodia has found it possible to prolong the survival of untreated HIV-infected adults with very weak immune systems and newly diagnosed tuberculosis by starting anti-HIV ...

Resistance to artemisinin, the main drug to treat malaria, is now widespread throughout Southeast Asia, among the Plasmodium falciparum parasites that cause the disease and is likely caused by a ...

Overall Count and Share for 'NIH NIAID International Centers for Excellence in Research (ICER) - Cambodia' based on the 12-month time frame mentioned above. Note: Articles may be assigned to more ...

A drug-resistant malaria parasite from southeast Asia can infect African mosquitoes, said a study Tuesday, boosting fears that a hard-to-cure variant of the disease could reach the world's most ...

More news: Supreme Court blocks use of affirmative action at Harvard, UNC in blow to diversity efforts Marrazzo to oversee $6.3 billion budget. In her new role, Marrazzo will oversee NIAID’s $6. ...

NIAID recently established CoVPN (COVID-19 Prevention Network) with the goal of registering a million volunteers, a pool that ideally will represent a wide variety of demographics for the ...